Cite Filings / RAPP / 0001172661-26-001034

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Rapport Therapeutics, Inc. Filed 2026-02-17 Acc 0001172661-26-001034

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-02-19 4 Chief Executive Officer sold 10,916 shares at an average $29.35 ($320,373)
2026-02-19 4 Chief Scientific Officer sold 8,500 shares at an average $29.02 ($246,655)
2026-02-17 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-11-14 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…